IP Valuation isn’t a dark art, the way to approach it is to use sound methodology and a deep understanding of technology, its place in the market and the associated IP. The talk will cover:
- -The when and the why of IP valuation
- -Three main methodologies
- -Sharing value in IP transactions
- -Getting to deal terms
SPEAKER: Andrew Tingey – Director Licensing & IP Transactions, Symbiosis IP (part of Gateley)
Andrew Tingey is a leading IP strategist with over 20 years’ experience in a variety of commercial roles centred around licensing and other IP-based transactions, having been nominated for the “IAM300 Global Leaders” list of the world’s leading IP strategists for four consecutive years.
Andrew holds a first-class honours degree in Biochemistry from the University of York, a PhD in Biochemistry from the University of Leicester, and a triple-accredited MBA from the Open University Business School. Andrew has also held Certified Licensing Professional accreditation since 2012.
Andrew has a real “hands-on” experience of dealmaking in hundreds of IP-based transactions from the perspectives of big corporate, venture capital and top-tier technology transfer offices. Andrew has successfully completed several IP transaction projects for clients in multiple sectors, including in and out licensing, with an emphasis on valuation and determination of acceptable deal terms.
Andrew was previously a Principal Consultant and Director at IP Pragmatics (now Wellspring), and Head of Commercialisation for Imperial College London, overseeing the formation of dozens of start-up companies and the completion of over 300 licence agreements. He has also held roles as Senior Director, Licensing & IP Strategy at Eagle Genomics and Director of Licensing at Royal DSM NV.
LES Member – £35
LES Member Guest (must register with member) – £40
Non Member – £45
Group booking discounts available upon request to the LES B&I Admin Office
Pricing includes light food and drinks.